BetterScholar BetterScholar
8
Role
Title
Level Year L/R
🐜 Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.
18 auth. C. Sternberg, K. Fizazi, F. Saad, N. Shore, U. de Giorgi, D. Penson, U. Ferreira, E. Efstathiou, K. Madziarska, M. Kolinsky, ... D. Cubero, B. Noerby, F. Zohren, Xun Lin, K. Modelska, J. Sugg, J. Steinberg, M. Hussain
8 2020
8
🐜
🦁 “Burnout in Medical Oncology Fellows: a Prospective Multicenter Cohort Study in Brazilian Institutions”
15 auth. D. Cubero, R. R. L. Fumis, T. H. Sá, A. Dettino, F. O. Costa, B. M. Eyll, Carlos Beato, F. Peria, A. Mota, J. Altino, ... S. J. Azevedo, D. R. Rocha Filho, Melba Moura, Á. Lessa, A. del Giglio
5 2015
5
🦁
🦁 Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study
D. Cubero, A. Giglio
5 2010
5
🦁
🐜 Purified Dry Extract of Paullinia cupana (Guaraná) (PC-18) for Chemotherapy-Related Fatigue in Patients with Solid Tumors: An Early Discontinuation Study
13 auth. A. D. del Giglio, D. Cubero, T. Lerner, Ricardo Tuma Guariento, Renata Guise Soares de Azevedo, H. Paiva, Cecilia Goldman, Bruno Carelli, F. Cruz, F. Schindler, ... L. Pianowski, Leandro Luongo de Matos, A. Giglio
5 2013
5
🐜
🐜 Uncaria tomentosa (cat's claw) improves quality of life in patients with advanced solid tumors.
10 auth. Larissa Carvalho Lopes de Paula, F. Fonseca, F. Perazzo, F. Cruz, D. Cubero, D. Trufelli, ... S. Martins, P. Santi, Eliana Araújo da Silva, A. del Giglio
4 2015
4
🐜
🦁 Cutaneous side effects of molecularly targeted therapies for the treatment of solid tumors
10 auth. D. Cubero, B. Abdalla, J. Schoueri, Fabio Iazetti Lopes, K. Turke, J. Guzman, ... A. del Giglio, Carlos D’Apparecida Santos Machado Filho, V. Salzano, Dolores Gonzalez Fabra
4 2018
4
🦁
🐜 Curcuma longa (Turmeric) for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Pilot Study
7 auth. Vanessa Armenio Scontre, J. C. Martins, Cláudia Vaz de Melo Sette, Haila Mutti, D. Cubero, F. Fonseca, ... A. del Giglio
4 2018
4
🐜
🐜 Final overall survival (OS) from PROSPER: A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic castration-resistant prostate cancer (nmCRPC).
19 auth. C. Sternberg, K. Fizazi, F. Saad, N. Shore, U. Giorgi, D. Penson, U. Ferreira, P. Ivashchenko, E. Efstathiou, K. Madziarska, ... M. Kolinsky, D. Cubero, B. Noerby, F. Zohren, Xun Lin, K. Modelska, J. Sugg, J. Steinberg, M. Hussain
4 2020
4
🐜